Key result
Deleting miR-130b/301b in mice reduces visceral adiposity and weight gain while improving glucose tolerance.
Why the study?
The role of the adipose-expressed miR-130b/301b cluster in regulating thermogenic beige adipogenesis was unknown.
The miR-130b/301b cluster suppresses beige adipogenesis via PGC-1α and AMPK signaling, making it a potential therapeutic target against obesity and metabolic disorders.
Hypothesis-generating for miR-130b/301b as a metabolic target; leaves open translation to human obesity or diabetes.
Thermogenic brown or beige adipocytes dissipate energy in the form of heat and thereby counteract obesity and related metabolic complications. The miRNA cluster miR-130b/301b is highly expressed in adipose tissues and has been implicated in metabolic diseases as a posttranscriptional regulator of mitochondrial biogenesis and lipid metabolism. We investigated the roles of miR-130b/301b in regulating beige adipogenesis in vivo and in vitro. miR-130b/301b declined in adipose progenitor cells during beige adipogenesis, while forced overexpression of miR-130b-3p or miR-301b-3p suppressed uncoupling protein 1 (UCP1) and mitochondrial respiration, suggesting that a decline in miR-130b-3p or miR-301b-3p is required for adipocyte precursors to develop the beige phenotype. Mechanistically, miR-130b/301b directly targeted AMP-activated protein kinase (AMPKα1) and suppressed peroxisome proliferator-activated receptor γ coactivator-1α (Pgc-1α), key regulators of brown adipogenesis and mitochondrial biogenesis. Mice lacking the miR-130b/301b miRNA cluster showed reduced visceral adiposity and less weight gain. miR-130b/301b null mice exhibited improved glucose tolerance, increased UCP1 and AMPK activation in subcutaneous fat (inguinal white adipose tissue [iWAT]), and increased response to cold-induced energy expenditure. Together, these data identify the miR-130b/301b cluster as a new regulator that suppresses beige adipogenesis involving PGC-1α and AMPK signaling in iWAT and is therefore a potential therapeutic target against obesity and related metabolic disorders.
No takes yet. Share an insight, caveat, or question.
Luo et al. (2022) studied Obesity and metabolic disorders. miR-130b/301b deletion or overexpression vs. Wild-type or control was evaluated on Beige adipogenesis, weight gain, and glucose tolerance. Mice lacking the miR-130b/301b cluster showed reduced visceral adiposity, less weight gain, improved glucose tolerance, and increased response to cold-induced energy expenditure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: